Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
16.74
-0.09 (-0.53%)
At close: Nov 20, 2024, 4:00 PM
16.01
-0.73 (-4.36%)
Pre-market: Nov 21, 2024, 7:34 AM EST
Centessa Pharmaceuticals Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for CNTA stock have an average target of 23.71, with a low estimate of 11 and a high estimate of 35. The average target predicts an increase of 41.64% from the current stock price of 16.74.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CNTA stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $24 → $28 | Strong Buy | Maintains | $24 → $28 | +67.26% | Nov 15, 2024 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $11 → $26 | Hold → Buy | Upgrades | $11 → $26 | +55.32% | Sep 19, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $33 | Strong Buy | Initiates | $33 | +97.13% | Sep 19, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $20 → $35 | Buy | Maintains | $20 → $35 | +109.08% | Sep 16, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $20 → $24 | Strong Buy | Maintains | $20 → $24 | +43.37% | Sep 11, 2024 |
Financial Forecast
Revenue This Year
n/a
from 6.85M
Revenue Next Year
n/a
EPS This Year
-1.67
from -1.57
EPS Next Year
-1.74
from -1.67
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 57.3M | ||
| Avg | n/a | n/a | 28.5M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.59 | -1.56 | -1.44 |
| Avg | -1.67 | -1.74 | -1.73 |
| Low | -1.72 | -1.97 | -2.08 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.